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Abstract.  The onset of muscle cell differentiation is 
associated with increased transcription  of muscle- 
specific mRNA.  Studies from this  laboratory, using 
19-d embryonic rat skeletal muscle,  suggest that addi- 
tional,  posttranscriptional  controls regulate maturation 
of muscle tissue via a quantitative effect upon transla- 
tion, and that the regulatory component may reside 
within the poly A- RNA pool (Nathanson,  M.  A., 
E. W.  Bush,  and C.  Vanderburg.  1986. J.  Biol.  Chem. 
261:1477-1486).  To further characterize muscle cell 
translational  control, embryonic and adult total RNA 
were separated into oligo(dT)cellulose-bound (poly A +) 
and -unbound (poly A-) pools.  Unbound material  was 
subjected to agarose gel electrophoresis to resolve con- 
stituents of varying molecular size and mechanically 
cut into five fractions.  Material of each fraction was 
electroeluted and recovered by precipitation.  Equiva- 
lent loads of total RNA from 19-20-d embryonic rat 
skeletal muscle exhibited a 40%  translational  inhibi- 
tion in comparison to its adult counterpart.  Inhibition 
was not due to decreased message abundance because 
embryonic, as well as adult muscle, contained equiva- 
lent proportions of poly A ÷ mRNA.  An inhibition as- 
say, based upon the translatability  of adult RNA and 
its  inhibition  by embryonic poly A- RNA, confirmed 
that inhibition  was associated with a  160-2,000-nt 
poly A- fraction.  Studies on the chemical composition 
of this fraction confirmed its RNA composition, the 
absence of ribonucleoprotein,  and that its activity was 
absent from similarly  fractionated adult RNA.  Rescue 
of inhibition  could be accomplished by addition of ex- 
tra lysate or mRNA; however, smaller proportions of 
lysate were required,  suggesting a  strong interaction of 
inhibitor and components of the translational  appara- 
tus.  Additional  studies demonstrated that the inhibitor 
acted at the level of initiation,  in a dose-dependent 
fashion.  The present studies confirm the existence of 
translational  control in skeletal muscle and suggest 
that it operates at the embryonic to adult transition.  A 
model of muscle cell differentiation,  based upon tran- 
scriptional control at the myoblast level, followed by 
translational  regulation at the level of the postmitotic 
myoblast and/or myotube, is proposed. 
D 
FFERENTIATION of skeletal  muscle begins with the 
appearance of myogenic regions within a previously 
homogeneous mass of mesenchymal  cells (Searls et 
al.,  1972).  Each  myogenic  region consists  of a  group of 
proliferating,  mononucleate myoblasts  amid other postmi- 
totic myoblasts that are fusing into syncytial myotubes.  It is 
now clear from in vitro studies that fusion is sensitive to fac- 
tors such as nutrient supply (Konigsberg,  1971, 1977; O'Neill 
and Stockdale,  1972; Doering and Fischman,  1974; White 
et al.,  1975) and  fibroblast  growth factor (Linkhart  et al., 
1980, 1981). The presence and/or addition of serum or fibro- 
blast growth  factor  to cultured myoblasts  is  sufficient  for 
myoblasts to remain in the proliferative  pool rather than un- 
dergo fusion. A variety of substances other than serum and 
fibroblast growth  factor  influence  fusion.  Some of them, 
such as DMSO (Blau and Epstein,  1979) and transforming 
growth factor beta (Massague et al.,  1986), inhibit both fu- 
sion and muscle-specific  protein synthesis.  Others, such as 
lowered  Ca  ++ concentrations  or EGTA,  affect only fusion 
(see below); however, not all  species respond similarly  to 
EGTA  (Shainberg  et al.,  1971). In the  well-characterized 
avian system, at least,  and in nonfusing  variants of an avian 
myogenic  line  (Ls; Kaufman  et al.,  1977),  it is clear that 
withdrawal  from the cell cycle is a requirement for fusion, 
but that fusion is not an obligate requirement for the initia- 
tion of muscle-specific  protein synthesis. 
Messenger RNA for muscle-specific proteins is known to 
occur in limited abundance in myoblasts before fusion (Young 
et al.,  1975; Buckingham  et al.,  1976; Yablonka and Yaffe, 
1977; Devlin  and Emerson,  1979; Jain and Sarkar,  1979; 
Benoff and Nadal-Ginard,  1979; Doetschman et al.,  1980; 
Zevin-Sonkin and Yaffe, 1980; Shani et al., 1981; Nadal-Gi- 
nard et al., 1982; Saidapet et al., 1982). Fusion is followed 
by a  burst  of transcription  that  enriches  muscle-specific 
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Emerson,  1979;  Hastings and  Emerson,  1982;  Medford 
et al.,  1983; see Paterson and Bishop, 1977).  However,  fu- 
sion is not the trigger for increased transcription, as fusion- 
blocked myoblasts show similarly increased rates of transcrip- 
tion (Yaffe and Dym, 1972;  Dym et al.,  1979) and protein 
synthesis (Emerson and Beckner,  1975; Merlie and Gros, 
1976; Moss and Strohman, 1976; see Trotter and Nameroff, 
1976). Control at the transcriptional level has therefore re- 
ceived considerable attention. 
While it is clear that a battery of muscle-specific genes are 
activated after fusion, young myotubes do not contain abun- 
dant myofibrils.  It is also known that some muscle-specific 
proteins are not translated with equal efficiency or at the 
same time as others, in spite of the presence of their respec- 
tive mRNAs (Nathanson et al.,  1986). 
A classic example of translational control has been studied 
in Escherichia coli, where synthesis of ribosomal proteins is 
controlled by feedback regulation of the proteins upon their 
mRNA (Yates and Nomura, 1981). In mammalian cells, there 
are also numerous examples where the control of gene ex- 
pression occurs at the level of translation, including changes 
in protein synthetic rates during mitosis, nutrient depriva- 
tion, heat shock, and virus infection (Hershey et al., 1984). 
U-rich RNAs which act as inhibitors of translation have been 
described in Artemia embryos (Lee-Huang et al., 1977), rat 
calvaria (Zeichner and Breitkreutz, 1978), rat liver (North- 
emann et al., 1980), and rabbit reticulocytes (Dionne et al., 
1982).  The frequency with which posttranscriptional (i.e., 
translational) control mechanisms occur in eukaryotes sug- 
gests that this process may also play a regulatory role in pro- 
tein synthesis of skeletal muscle. 
Posttranscriptional regulation has been suggested to occur 
in skeletal muscle via release of mRNA from mRNP parti- 
cles (Brawerman, 1974; Bester et al., 1975; Buckingham et 
al., 1976; Jain and Sarkar, 1979; Doetschman et al., 1980), 
or via increased stability of newly transcribed mRNA (Buck- 
ingham et al.,  1974,  1976; Medford et al.,  1983;  Carniero 
and Schiebler, 1984). There is agreement that at least some 
muscle-specific mRNA occurs as mRNP, although it is not 
known with certainty how mRNPs control the availability of 
mRNA at the time of fusion, or whether newly transcribed 
mRNA is preferentially translated (Dym et al., 1979; Doetsch- 
man et al., 1980). The occurrence of  message-specific initia- 
tion factors in skeletal muscle (Thompson et al., 1973) and 
other eukaryotic cells (Wigle, 1973; Nudel et al., 1973),  as 
well as RNAs that inhibit translation (Mukherjee and Sarkar, 
1981; Sarkar et al.,  1981; Mroczkowski et al.,  1984),  have 
also  been  described.  One  of these  translational  control 
RNAs, tcRNA, has been isolated from eIF-3 preparations 
of 19-d embryonic chick skeletal muscle (Heywood et al., 
1974) and from polysomes and mRNP of 13-14-d embryonic 
skeletal muscle (Bester et al., 1975; Heywood and Kennedy, 
1976). The tcRNA from 19-d embryonic skeletal muscle ap- 
pears to be the component responsible for message-specific 
initiation of myoglobin synthesis  (see  Thompson  et  al., 
1973), whereas the mRNP-associated tcRNA was capable of 
blocking translation of homologous (skeletal muscle) mRNA 
(Bester et al., 1975; Heywood et al., 1974, 1975) by binding 
the 5' and 3' poly A regions of mRNA (Kennedy et al., 1974, 
1978; Bester et al.,  1975; Heywood et al.,  1975). 
Another RNA capable of inhibiting translation, has been 
isolated from  10  S,  postpolysomal RNP particles of em- 
bryonic chick muscle (Sarkar et al., 1981; Pluskal and Sar- 
kar, 1981). This RNP (termed iRNP) contained a 4 S RNA 
(iRNA) that was nonspecific in its inhibitory activity. The 
proteins of iRNP could not reassociate with globin mRNA, 
suggesting that there was  specificity to the association of 
iRNA and iRNP proteins (Mukherjee et al., 1981). The pro- 
teins themselves were devoid of inhibitory activity (Mukher- 
jee and Sarkar,  1981). Mechanistic studies suggested that 
iRNA acted at the level  of initiation to inhibit binding of 
mRNA to 43 S initiation complexes (Winkler et al., 1983). 
Recent  studies  in  this  laboratory  have  also  implicated 
translational control as a posttranscriptional regulatory step 
in the differentiation of skeletal muscle (Nathanson et al., 
1986). Our data suggested that skeletal muscle gene regula- 
tion occurred at three levels. Alpha actin was regulated tran- 
scriptionally, whereas alkali light chains were controlled at 
the translational level, and regulation of myosin heavy chain 
and light chain 2  was of the mixed transcriptional-trans- 
lational type. One feature of these studies was that the inhibi- 
tory component could not be identified in adult skeletal mus- 
cle, suggesting that translational regulation may be a feature 
of embryonic tissue. Data from another laboratory was con- 
sistent with these findings and suggested that muscle "house- 
keeping" proteins were subject to transcriptional control, 
whereas  muscle-specific proteins  such as  alpha  and beta 
tropomyosin were  subject  to  transcriptional-translational 
regulation, and others were subject to purely translational 
regulation (Endo and Nadal-Ginard,  1987). 
In skeletal muscle there appears to be two major methods 
of exerting posttranscriptional control over translationally 
competent mRNA. One is by sequestering mRNA as mRNP, 
while the second acts upon translation itself, presumably via 
direct interaction of an RNA with the translational appara- 
tus. The present studies were undertaken to further charac- 
terize translational regulation of embryonic vs. adult skeletal 
muscle and to identify the component(s) responsible for in- 
hibited translation in embryonic tissue. 
Materials and Methods 
Glassware was baked (250°C for 5 h) and solutions were autoclaved (121°C 
for 15 rain) to destroy nucleases. Water was deionized (Milli-Q,  18 meg- 
ohm/cm  3)  and  treated with 0.1% diethylpyrocarbonate to  inactivate nu- 
cleases; plasticware was soaked in 0.1%  diethylpyrocarbonate for  1 h  at 
room temperature. Diethylpyrocarbonate was destroyed by autoclaving. 
Oligo(dT)-cellulose (type III)  was purchased from Collaborative Re- 
search, Inc.  (Waltham, MA).  Phenol (ultra-pure), pmteinase K, agarose 
(electrophoresis grade), dithiothreitol (DTT; ultra-pure), a 0.16-1.7-kb RNA 
ladder, a 7.5-kb marker RNA, and  ~4C-labeled protein molecular weight 
standards were from Bethesda Research Laboratories (Gaithersburg, MD). 
Glycogen (molecular biology grade) was purchased from Boehringer Mann- 
heim Biochemicals (Indianapolis, IN). In vitro translation kits, [aSS]methi- 
onine, alpha and gamma [32p]ATP, and rabbit reticulocyte lysate were pur- 
chased from New England Nuclear (Boston, MA). Casamino acids were 
from Difco Laboratories, Inc. (Detroit, MI). Methylmercuric(II) hydroxide 
was purchased from the  Alpha Catalog  Chemicals Division of Morton 
Thiokol, Inc. (Danvers, MA). T4 polynucleotide kinase was from United 
States Biochemical Corp.  (Cleveland, OH).  Sephadex G-50,  RNase-free 
DNase I, calf intestinal alkaline phosphatase, and unlabeled protein molec- 
ular weight standards were from Pharmacia Fine Chemicals (Piscataway, 
N J).  Cycloheximide, ribonuclease A, diethylpyrocarbonate, and calf thy- 
mus DNA were from the Sigma Chemical Co. (St. Louis, MO). Micrococ- 
cal  nuclease was from Worthington Biochemical Corp.  (Freehold,  NJ). 
B.S.A. (Fraction V) was from Miles Laboratories Inc. (Naperville, IL). 3,5- 
diaminobenzoic acid, XAR-5 x-ray film, and photographic chemicals were 
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Promega Biotech (Madison, WI). Ethidium bromide was from International 
Biotechnologies Inc. (New Haven, CT). Gelcode silver stain was from the 
Pierce Chemical Co. (Rockford, IL). Quick Blot mRNA isolation kits and 
Elutrap membranes were from Schleicher and Schuell, Inc. (Keene, NH). 
Acrylamide stock solutions (Acrylagel) and scintillation cocktail (Ultrafluor 
or Ecoscint) were purchased from National Diagnostics, Inc. (Somerville, 
N J).  Timed pregnant,  Sprague-Dawley albino rats were purchased from 
Taconic Farms, Inc. (Germantown, NY). Reagents were certified as RNase- 
free or nuclease-free whenever possible; all other components were of re- 
agent grade. 
Isolation and Fractionation of  RNA 
RNA was isolated from 20-d embryonic rat thigh muscle as described previ- 
ously (Nathanson et al.,  1986). Tissue was extracted by the guanidinium 
isothiocyanate method (Chirgwin et al.,  1979) and RNA was isolated in a 
pellet by isopyknic density gradient centrifugation through cesium trifluoro- 
acetate (4:1, [vol/vol]; starting density 1.6 g/ml). Gradients were established 
by centrifugation at 486,500 gh at 20°C in a  model SW 50.1  rotor (Beck- 
man Instruments, Inc., Palo Alto, CA). Pelleted material was washed twice 
with ice-cold 70% ethanol, dissolved in 10 mM Tris-HC1, pH 8, containing 
1 mM EDTA (TE),  and SDS was added to a final concentration of 0.1%. 
Protease K was added to a  final concentration of 200 p,g/ml and digestion 
was carried out for 30 min at 370C. Samples were chilled on ice and sequen- 
tially extracted with equal volumes of phenol followed by phenol-chloro- 
form (1:1) and chloroform, and precipitated with 2.5 vol of ice-cold absolute 
ethanol and 0.1  vol of 3  M  sodium acetate.  Precipitates were recovered 
by centrifugation and RNA was dissolved in water. Quantitation was per- 
formed spectrophotometrically at 260 nm and corrected for nonnucleic acid 
absorption at 300 nm. Purity was assessed by the ratio of absorbance at 
260:280 nm. 
Embryonic RNA was poly A selected as described previously (Nathan- 
son et al.,  1986).  Poly A- RNA (oligo[dT]cellulose-unbound) was diluted 
l:l  in a 2×  electropboresis sample buffer containing l0 mM methylmer- 
curic hydroxide, 20% sucrose, 0.01% bromophenol blue, and 0.01% xylene 
cyanol, and held at room temperature for 20 min. An aliquot containing 50 
~tg of each RNA sample was loaded into l-cm wells of a 20.0  x  40.0  x 
0.5-cm horizontal 1.5% agarose gel. Electrophoresis was carried out at 4°C 
with buffer recirculation (buffer consisted of 50 mM boric acid, 5 mM so- 
dium borate, 10 mM sodium sulfate, 1 mM EDTA, pH 8.2) and 100 V (con- 
stunt) for 3 h or until the bromophenol blue tracking dye had traveled a dis- 
tance of 12 cm. One lane of each gel was removed and stained with 5 I.tg/ml 
ethidium bromide in 0.5 M ammonium acetate for 15 min. After destaining 
for 30 min in 0.5 M ammonium acetate, the banding pattern was visualized 
under long wave UV transillumination, and the preparative gel marked in 
comparison to the positions of hands in the stained lane. Each lane of the 
preparative gel was then cut into five fractions and fractions were pooled. 
Each pool was incubated for 29 min each in three changes of 100 mM DTT 
at room temperature, followed by a final incubation in electroelution buffer 
(40 mM Tris-HCl, 0.4 mM EDTA,  10 mM NaCI, and 100 U/ml RNasin) 
overnight at 4°C. Gel slices were loaded into an Elutrap electroelution ap- 
paratus (Schleicher and Schuell, Inc.) and electroeluted at 100 V (constant) 
for 3 h at room temperature. Eluted RNA was collected in a volume of 800 
~tl, phenol extracted, and precipitated with 2.5 vol of ethanol in the presence 
of 0.1 vol of sodium acetate and 1 lag glycogen at -80°C. Precipitated RNA 
was collected by centrifugation at  13,000  gma~ for 30 rain at 4°C, washed 
once with 70%  ethanol,  dried by evaporation, and redissolved in sterile 
water. 
In Vitro Translation 
In vitro translation of total RNA or oligo(dT)-selected poly A ÷ mRNA was 
performed with a message-depleted reticulocyte lysate system. Each 12.5-1al 
translation contained 90%  lysate,  10 txCi  t.-[3SS]methionine,  and RNA at 
concentrations described below.  The final translation mixture contained 
2.2 mM magnesium and  100 mM potassium (as acetate).  Before transla- 
tion,  RNA samples were  heated  in a  65°C  water  bath  for  10  min and 
quenched on  ice.  Translation was performed at 30°C for 60 min. After 
translation, RNA was degraded by the addition of 40 U of RNase A and 
reincubation at 30°C for 30 min. This step was omitted during nuclease in- 
duction experiments.  Translation products were  analyzed by  SDS-PAGE 
through 10% separating gels (10%T, 3%C; notation of Hjerten, 1962) with 
4% stacks (Laemmli, 1970), at 40 mA per gel, and at 20°C. Samples were 
prepared for electrophoresis by dilution with 4 vol of sample buffer (O'Far- 
rell,  1975),  modified to contain 4.0%  SDS, and heated in a boiling water 
bath for 2-3 min. Gels were routinely stained with Coomassie Blue R-250 
and translation products were visualized by fluorography (Laskey and Mills, 
t975). Quantitation was performed by precipitation with TCA as described 
below. 
TCA Precipitation 
Aliquots of 1.5 I.tl were removed from in vitro translations, placed into 1 ml 
of prewarmed  1  N  NaOH  containing  1.5%  hydrogen peroxide,  and  in- 
cubated at  37°C for  10 min. 4  ml of ice-cold 25%  TCA containing 2% 
casamino acids were added and the mixture held on ice for 30 min. Each 
sample was then vacuum filtered  through GF/C  filters  (Whatman Inc., 
Clifton, NJ) and washed once with 10 ml of ice-cold 8%  TCA and twice 
with 1 ml each of acetone. 35S cpm were determined by scintillation count- 
ing of the dried filters in 10 ml of cocktail in a scintillation counter (model 
LS-8100; Beckman Instruments, Inc.) in the automatic quench correction 
mode. 
Enzyme Digestions 
Experiments to determine protease K sensitivity were performed for up to 
20 min at 30°C in a 20 p.l reaction mixture containing 10 p.g RNA, 50 U 
of protease K, 10 mM Tris-HC1, pH 8.0, and 1 mM EDTA. Digestion with 
RNase A was performed for up to 1 h at room temperature in a 20-p.I reac- 
tion mixture containing 10 p.g RNA, 5 ng of RNase A,. 10 mM Tris-HCl, 
pH 8.0, and 1 mM EDTA. Aliquots of protease K and RNase A digestions 
were taken at the times indicated under Results. Digestion with DNase I was 
performed for 30 min at room temperature in a 50-p.l reaction volume con- 
taining 10 I.tg RNA,  10 U of RNase-free DNase I, 40 mM Tris-HC1, pH 
7.9,  10 mM NaCI, and 6 mM MgClz. RNase A digestion of a protein mo- 
lecular weight standard was used to confirm the absence of protease activity 
in this preparation and was performed for 40 min in the presence of 500 ng 
of the protein standard. Enzymatic digestions of RNA were stopped by ex- 
traction with phenol. Digests were analyzed by methylmercury-agarose gel 
electrophoresis as described above. For these experiments, the distal portion 
of each 1.5 % gel was replaced with 3.0 % agarose to trap potential digestion 
products. 
Micrococcal nuclease was used to digest fraction 4  RNA (free of con- 
taminant protein and DNA) to demonstrate that the remaining nucleic acid, 
which could only be RNA, was responsible for the observed biological ac- 
tivity (i.e., inhibition of translation). Digestion was performed at 37°C in 
a  12.5  I11 reaction containing,  10 ~g of RNA, 0.016  mM CaCI2, 0.08 M 
borate buffer, pH 8.8, and 8 p.g of nuclease. The enzyme was prepared as 
a 2-mg/ml stock containing 0.1% BSA. Reactions were carried out for the 
times indicated  under  Results.  At  the appropriate  time,  reactions  were 
stopped by the addition of 7.5 I.tl of a  10-mg/ml EGTA stock. Digests were 
precipitated with ethanol, in the presence of glycogen as described above, 
dissolved in 5 p.l of water, and added to in vitro translations assuming  quan- 
titative recovery. EGTA was maintained at sufficient concentration to inhibit 
the nuclease in the digest and lysate. The presence or absence of translation 
products was evaluated by SDS-PAGE. 
Quantitation of DNA and Poly A + RNA from 
Embryonic Muscle of Various Developmental  Stages 
RNA and DNA were isolated as nuclear and cytoplasmic fractions of skele- 
tal muscle obtained from adult, 6-wk-old, 5-d neonate, 20-d embryonic, and 
16-d embryonic rats. Leg and thigh muscle from animals of each of these 
ages was collected by dissection as described previously (Nathanson et al., 
1986) and enzymatically disaggregated into single cell suspensions (Nathan- 
sou et al.,  1978).  Cell suspensions were washed 3 times on the centrifuge 
in Hanks' balanced salt solution (HBSS),  containing 50 I.tg/ml cyclohexi- 
mide, 2 U/ml RNasin, and 5 mM DTT, at 400 gm~x for 5 min, and resus- 
pended in a  fresh aliquot of the same solution. Fractionation into nuclear 
and cytoplasmic pools was performed using a modification of the protocol 
supplied with the Quick-Blot kit (Schleicher and Schuell, Inc.). 1 ml of each 
cell suspension was mixed with 50 ktl of Brij 35 and gently vortexed. 50 
I~1 of sodium deoxycholate was then added and, after gentle vortexing, the 
mixture was incubated on ice for 5 min. The mixture was then centrifuged 
for 5 min at  100 gm~x tO pellet nuclei. Cytoplasmic fractions (supernates) 
were treated with RNase-free DNase I and proteinase K, phenol extracted, 
and precipitated  with ethanol as  described above.  Nuclear  pellets  were 
homogenized by sonication in sterile water, on ice, for 30-40 s in a volume 
of 500 I11. Quantitation of total DNA content in each of the nuclear pellets 
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son and Hay,  1980).  RNA contents of cytoplasmic fractions were normal- 
ized with respect to the DNA content of the respective nuclear pellet. An 
aliquot of each cytoplasmic fraction equivalent to a  volume representing 
200 ng of DNA was assayed for total RNA content by UV spectrophotome- 
try at 260 nm and corrected for nonnucleic acid absorption at 300 nm. This 
RNA was then mixed with 50 Ixl of oligo(dT)cellulose in binding buffer, and 
incubated with shaking for 1 h at room temperature. The slurry was cen- 
trifuged at 9,000 gmax for 5 min to pellet the oligo(dT)cellulose matrix. Su- 
pernates were carefully removed and assayed for their RNA content as 
above.  Oligo(dT)cellulose pellets were washed once with 50 pl of binding 
buffer, resuspended in 50 I.tl of elution buffer, and incubated for 1 h at room 
temperature with shaking. Oligo(dT)cellulose was pelleted as before, and 
the eluted supernates were assayed for their RNA content. 
Nuclease Induction 
Nuclease induction as a means of limiting translation in vitro was studied 
using an end-labeled 7.5-kb marker RNA as a substrate in translations lack- 
ing isotope and primed with RNAs isolated above. Potential degradation 
products were separated by methylmercury-agarose  gel electrophoresis. The 
marker RNA (150 pmol) was dephosphorylated with 9.0 U of calf alkaline 
phosphatase. Dephosphorylation was carried out in a buffer consisting of 
0.05 M Tris-HC1,  pH 9.0,  1 mM MgCI2, 0.1 mM ZnC12, and 1 mM sper- 
midine for 30 min at 37°C in a volume of 200 pl. 40 pl of 10× STE buffer 
(100 mM Tris-HC1,  pH 8.0, 1 M NaC1,  10 mM EDTA), 20 pl of 10% SDS, 
and 140 pl of water was then added and the mixture incubated at 68°C for 
15 min to inactivate the enzyme. The mixture was extracted twice with phe- 
nol/chloroform (1:1) followed by  two  extractions with  chloroform,  and 
finally precipitated with 2.5 vol of absolute ethanol, 0.1 vol of 3.0 M sodium 
acetate, and 1 lag glycogen. 50 pmol of 5'-dephosphorylated RNA ends were 
end-labeled with 30 U of T4 polynucleotide kinase, in a reaction mixture 
containing  100  pCi  gamma(32p)ATP  (New England Nuclear;  3,000  Ci/ 
mM) and  10  t.tl of 10×  kinase buffer (0.5  M  Tris-HC1,  pH  7.6, 0.1  M 
MgCl2,  50 mM DTT,  1 mM spermidine, 1 mM EDTA)  in a total volume 
of 50 [tl at 37°C for 30 min. The reaction was stopped by addition of 2 pl 
of 0.5 M EDTA, extracted with phenol/chloroform, and precipitated with 
ethanol. By virtue of the poly A tails on the Z5-kb RNA marker, labeled 
RNA  was  separated  completely from  unincorporated  isotope by  oligo- 
(dT)cellulose chromatography as described previously (Nathanson et al., 
1986).  Two peaks of 32p activity were identified by counting of the frac- 
tions eluted from the oligo(dT) column. The second peak contained the end- 
labeled RNA; these fractions were pooled, precipitated with ethanol, and 
recounted. After in vitro translation in the presence of 20,000 cpm per sam- 
ple of the end-labeled RNA, translations were digested with proteinase K, 
phenol extracted, and ethanol precipitated before loading 5,000  cpm per 
sample onto composite 1.5:3.0%  agarose-methylmercury gels (see above) 
along with DNA molecular weight standards. Standards consisted of phage 
lambda DNA, digested to completion with Hind III endonuclease, and la- 
beled with alpha (32p)dATP. Restriction digests, containing 2  pg of input 
DNA in a  10-pl reaction volume, received 3  I.tl of nucleotide (3,000  Ci/ 
mM), 5 pl of 0.2-mM unlabeled dNTPs (lacking dATP), and 1 pl of DNA 
polymerase (Klenow). Labeling was carried out at room temperature for 30 
min and stopped by the addition of 70 pl of TNE buffer (10 mM Tris-HCl, 
pH 8.0, 100 mM NaC1,  1 mM EDTA),  5 ittl of 0.2 M EDTA, and 5 ~1 of 
10% SDS. Unincorporated isotope was removed by Sephadex G-50 chroma- 
tography,  and labeled lambda DNA was precipitated with ethanol in the 
Table I. Estimation of Translatable mRNA in Cytoplasmic 
Extracts from Rats of Various Ages 
Oligo (dT) selection (pg/103 nuclei)* 
Percent  Percent 
Bound (pg)  Unbound  (pg)  bound  recovery 
Adult  8.0  119.16  6.28  79.6 
6-wk-old  7.79  114.61  6.36  75.8 
5-d-old  9.45  128.25  6.86  81.6 
20-d embryo  8.77  129.22  6.35  73.3 
16-d embryo  10.32  122.40  7.77  78.7 
* All values are normalized  to the DNA content of an avian cardiac  muscle 
nucleus  (0.0065  pg). 
presence of 1 pg of glycogen. Electrophoresis was carried out for 24 h at 
30 mA constant current, in an electrophoresis buffer consisting of 35 mM 
Tris base, 35  mM NaH2PO4,  1 mM EDTA,  pH 7.7. Agarose gels were 
fixed in 8% TCA for 1 h at room temperature and blotted to dryness on filter 
paper (type 3MM; Whatman Inc.). Autoradiography was carried out for 
1 h at room temperature using a  single intensifying screen (type Cronex 
Quanta-III;  Dupont Co., Wilmington, DE). 
Initiation of  Protein Synthesis 
The assay for initiation of translation was performed using an in vitro system 
based on the  formation of an  NHz-terminal dipeptide, fMet-Val,  in  re- 
sponse to globin mRNA, as described (Cenatiempo et al.,  1983). 
Results 
Embryonic and Adult Rat Skeletal Muscle Contain 
Equivalent Proportions of Translatable mRNA 
We have previously  reported that RNA  isolated  from  19- 
20-d embryonic rat skeletal muscle (total RNA) directs less 
incorporation of labeled  methionine into TCA-precipitable 
material than equivalent amounts of total RNA from its adult 
counterpart (Nathanson et al.,  1986).  SDS-PAGE confirmed 
the  inhibition  of protein  synthesis.  However,  selection  of 
poly A + mRNA via oligo(dT)cellulose chromatography re- 
sulted  in  restoration of translation to levels  comparable to 
that of adult total RNA.  Based upon the additional finding 
that isolated embryonic and adult RNA both contained equiv- 
alent proportions of poly  A + RNA  (1-2 % of total  RNA), 
and  that only  poly  A ÷  RNA  (mRNA)  was translatable  in 
vitro, we sought to rule out variations in transcriptional ac- 
tivity that may give rise to an apparent enhancement of trans- 
lation in the adult. 
Total  RNA  was  isolated  from  cytoplasmic  extracts  of 
skeletal muscle from  16-d  embryonic through adult stages 
and  selected  for translatable  species  by  oligo(dT)cellulose 
chromatography. Data were normalized to "cell number" by 
DNA assay of the nuclear fractions using the DNA content 
of a single cardiac muscle cell nucleus (0.0065 pg) as a stan- 
dard. Cell number in these experiments refers to number of 
nuclei rather than actual number of cells. This convention is 
necessitated by the fact that skeletal muscle cells are mul- 
tinucleate;  production of mRNA  is thus related to mRNA 
producing units. It is impossible to express this data on a tis- 
sue mass or protein basis as these multinucleate cells contain 
greater  proportions  of  stable  protein  in  myofibrils  in  the 
adult,  in comparison to the embryo. The increased volume 
of adult cells may also not clearly relate to nuclear content 
as message turnover rates are not known for all  messages 
likely to be encountered. The results of this experiment indi- 
cated that cytoplasmic extracts at each stage contained ap- 
proximately equivalent amounts of mRNA,  and that its re- 
covery was consistent throughout the experiment (Table I). 
The results suggest that transcription of mRNA was constant 
from the onset of myoblast fusion ('~16 d of gestation) until 
adulthood,  or that the stability of translatable  species  was 
controlled throughout development to maintain a  constant 
cytoplasmic level. 
Partial Purification of Translational Inhibitor Activity 
The protocol for preparation of RNA used in the remainder 
of these experiments included extraction by guanidine iso- 
thiocyanate and recovery of RNA as a  pellet  from cesium 
The Journal  of Cell Biology,  Volume 107, 1988  1088 Figure 1. Fractionation of embryonic skeletal muscle poly A- RNA. (a) Preparative agarose gel. Lane 1, RNA ladder (2 ~tg); lane 2, em- 
bryonic rat skeletal muscle poly A- RNA (5 lag). Sizes of components of the RNA ladder are indicated on the left margin.  The arrow 
indicates the position of a band migrating near 10 kb. (b) Size estimation of RNA fractions. Tic marks on the right margin correspond 
to the RNA ladder in lane 7 and are shown in a of this figure. Preparative gels were cut into five fractions as indicated on the right margin. 
Lane 1, bovine ribosomal RNA (0.5 ~tg); lane 2, rabbit tRNA (0.25 I.tg); lane 3, adult total RNA (3 ~g); lane 4, embryonic total RNA 
(3 ~g); lane 5, adult poly A- RNA (3 ktg); lane 6, embryonic poly A- RNA (3 I-tg); lane 7, RNA ladder (1  lag). (c) Re-electrophoresis 
of fractions 1-5 excised from preparative gels and recovered by electroelution.  Each lane contains 5 lag of individual fractions as indicated. 
Overlap in the leading and trailing edges of fractions 2-5 indicated the possibility of overlap in RNA content, however, each fraction con- 
tained a single major RNA band. 
trifluoroacetate gradients. Residual protein was degraded by 
protease K,  followed by phenol and chloroform extraction 
(see Materials and Methods). OD260/280  ratios of 1.8 or high- 
er demonstrated that the preparations were largely devoid of 
protein. Insofar as the inhibitory activity associated with em- 
bryonic total RNA could be removed by oligo(dT)cellulose 
chromatography (Nathanson et al.,  1986), the starting mate- 
rial for these experiments consisted  of oligo(dT)cellulose- 
unbound  material.  Oligo(dT)-unbound  material  was  frac- 
tionated by methylmercury-agarose gel electrophoresis and 
recovered  by  electroelution.  In  preparative  gels,  samples 
contained well-defined bands near  10 kb (Fig.  1 a,  lane 2, 
arrow). Below 10 kb, the RNA migrated as a continuous dis- 
tribution with only weak evidence of banding. Conspicuous 
features included bands of ribosomal RNAs, and these bands 
were used as arbitrary guides for slicing of each lane into five 
fractions (see below). 
Initially, preparative gels were run in the presence of mo- 
lecular size markers,  however, the consistency with which 
each of the five fractions were resolved made the inclusion 
of standards unnecessary as a  routine procedure.  Accurate 
sizing of each fraction was performed on analytical gels and 
an example is shown in Fig.  1 b. Standards included bovine 
ribosomal RNA (lane 1 ), rabbit tRNA (lane 2), and an RNA 
ladder (lane 7; tic marks on right margin refer to these same 
standards as shown in Fig. 1 a, lane 1 ). For comparative pur- 
poses, both adult and embryonic total RNA (lanes 3 and 4, 
respectively) and  adult  and  embryonic oligo(dT)-unbound 
material (lanes 5 and 6, respectively) were included on this 
gel. We note that embryonic material differed from its adult 
counterpart by decreased ethidium bromide staining <28 S. 
Adult  material  also  contained  well-defined  bands  <18  S; 
these same bands appear faintly in embryonic samples, but 
are obscured by other more abundant species. The right mar- 
gin of Fig.  1 b  indicates the  slicing scheme applied to the 
preparative gels. Fraction 1 contained the band near 10 kb, 
fraction 2 contained material from fraction 1 up to, but not 
including,  the second major band (18 S rRNA),  fraction 3 
contained 18 S rRNA, fraction 4 contained material migrat- 
ing faster than 18 S to above a band of 5.8 S rRNA (160 nt), 
and fraction 5  included all smaller species.  In anticipation 
of data to be presented below, we note that fraction 4 con- 
rained a  heterogeneous population that fell within the  size 
range  of  160-2,000  bases  and  was  well-separated  from 
tRNA.  When  each  individual  fraction  was  resubjected  to 
electrophoresis,  they  contained  large  leading  and  trailing 
shoulders and some degree of overlap was apparent (Fig.  1 
c).  However, each fraction contained  sequences  unique  to 
that fraction. 
An assay for translational inhibitory activity was devised, 
based upon our observation that adult skeletal muscle total 
RNA translated in an uninhibited fashion. Thus, addition of 
fractionated, embryonic oligo(dT)-unbound material to adult 
total RNA should yield inhibition of in vitro translation  if 
that fraction contained such activity. Further,  6  lag of each 
embryonic, oligo(dT)-unbound fraction failed to direct pro- 
tein synthesis in vitro (data not shown) and should not con- 
tribute to the fluorographic patterns. Fluorographs prepared 
Vanderburg  and Nathanson  Control of Muscle Protein Synthesis  1089 Figure 2.  Cotranslation of fractionated embryonic poly A- RNA with adult total RNA. Each of the five fractions obtained from embryonic 
poly A- RNA (cf. Fig.  1 c) was added to in vitro translations containing 250 ng of adult muscle total RNA. The amount of each fraction 
added is indicated below each lane. Two microgram amounts of any fraction was found to be inhibitory,  indicating nonspecific overload 
of the translation system. Only fraction 4 was able to inhibit translation in a specific fashion. Translation in a completely uninhibited system 
is indicated in the lane on the far lefi. 
Figure  3.  Cotranslation of fractionated adult poly A- RNA with adult total RNA.  Five fractions were also obtained from adult muscle 
poly A- preparations  and cotranslated  with 250 ng of adult muscle total RNA.  Nonspecific inhibition was again observed at the 2-~tg 
level; however, no inhibition by adult fraction 4  was detected.  A  blank (no RNA) and an uninhibited translation are shown in the first 
two lanes. 
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complete inhibition when fraction 4 was present at 1-2 times 
the concentration of translatable (adult) RNA (Fig. 2).  No 
other fraction exhibited comparable activity. It is important 
to note that all fractions gave rise to partial inhibition when 
present at an eightfold excess; partial inhibition appeared to 
be the result of nonspecific inhibition, related to overload of 
the in vitro translation system by nontranslatable sequences. 
We also sought to confirm that inhibition was not present af- 
ter addition of adult-derived fraction 4; the data has con- 
firmed this point (Fig. 3). Data from translations containing 
adult  fractions also  yielded  inhibition  when  an  eightfold 
excess was added, consistent with nonspecific inhibition as 
described above. Evidence of inhibitory activity associated 
with embryonic fraction 4 indicates that this fraction repre- 
sents a partially purified, embryo stage-related, inhibitor of 
translation. 
We note again that the activity of fraction 4  appears to 
mimic the condition encountered in the embryo, that transla- 
tion of a given amount of total RNA is inhibited in compari- 
son to adult skeletal muscle. One concern is that the assay 
does not artificially add back RNA (i.e., fraction 4) in greater 
proportions than actually occur in embryonic and adult mus- 
cle.  Embryonic RNA does not resolve into bands,  as does 
DNA, but appears as a continuous distribution of sizes. Our 
fractionation procedure,  while reproducible,  is  limited by 
random  losses  encountered during  precipitation and elec- 
troelution,  and  consequently cannot result in  recovery of 
equivalent percentages of fraction 4 from each preparation. 
We cannot reliably estimate the amount of fraction 4 RNA 
in  a  given total  RNA pool.  The answer to this  important 
question must await purification and/or cloning of the active 
species. However, with regard to the preparations shown in 
Figs.  2  and  3,  embryonic poly A-  RNA  contained 8.8% 
fraction  4,  while  its  adult  counterpart  contained  13.5%. 
These values are similar enough to suggest that our proce- 
dure of adding back a  constant amount of each fraction 4 
does not result in artifactual inhibition. We believe that data 
presented in Figs.  2 and 3 is an accurate demonstration of 
in vivo conditions insofar as adult fraction 4 does not show 
inhibitory activity. 
Some lanes shown in Fig. 2, associated with fractions de- 
void of inhibitory activity, do indicate less translation prod- 
ucts than would be expected (lanes containing 0.25  gg of 
each fraction).  The entire series of experiments shown in 
Figs. 2 and 3 have been repeated twice, and on the basis of 
the combined data it appears that this is due to random varia- 
tion in quantitation of RNA. This data is not consistent with 
the presence of inhibitory activity in any fraction except frac- 
tion 4. 
Preliminary experiments, using unfractionated oligo(dT)- 
unbound material, demonstrated that translational inhibition 
could be achieved when this and adult total RNA were mixed 
together and held overnight at 4°C. Secondary structure was 
reduced by heat denaturation before translation. These mix- 
tures demonstrated a dose-dependent inhibition, requiring at 
least 10 lag of embryonic oligo(dT)-unbound material to in- 
hibit translation of 0.25 lag of adult total RNA.  After frac- 
tionation as described above, it no longer was necessary to 
preassociate  the  RNAs.  We  now  detect  inhibition  when 
250-500 ng of fraction 4 is added to a reaction containing 
250 ng of adult total RNA (Fig. 2), demonstrating purifica- 
tion of the inhibitory activity 20-40-fold. 
The Inhibitory Material of  Fraction 4 is 
Ribonucleic Acid 
Oligo(dT)cellulose-unbound material was subjected to en- 
zymatic digestion with either DNase I, protease K, or RNase 
A for varying periods of time to determine its composition. 
Analytical  scale  1.5%  methylmercury gels  were used  for 
separation and were cast with distal plugs of 3 % agarose to 
retain digestion products. Nucleic acid was visualized after 
staining  with  ethidium  bromide.  Preliminary  analysis 
demonstrated that the 10-kb band (cf. Fig.  1 a, lane 2) was 
the only component sensitive to DNase  I.  Digestion data 
confirmed that this band was composed of DNA, which co- 
isolated with oligo(dT)-unbound material (Fig. 4 a; compare 
undigested fraction I  in lane 4 with digested material in lane 
5). Examination of the electrophoretic pattern obtained after 
protease K digestion of fraction 1 demonstrated no altera- 
tions in the ethidium bromide profile, even after digestion for 
up to 20 min. Similarly, protease K digestion failed to alter 
the ethidium bromide staining pattern of total RNA prepara- 
tions treated with DNase I. Undigested RNA (Fig. 4 b, lane 
2) migrated in an identical fashion to material treated with 
the enzyme for up to 60 min (Fig. 4 b, lanes 3-6). Control 
digestions indicated that RNase A, while devoid of protease 
activity, did contain DNase activity. To avoid complications, 
digestion with RNase A was performed on a pool of fractions 
2-5 (Fig. 4 c, lane 2).  The data demonstrated degradation 
of the entire pool within 5-10 min (Fig. 4 c, lanes 3-8). 
The use of ribonuclease was avoided when digested mate- 
rial was to be translated in vitro. Poor or reduced translation 
of control (adult) mRNA indicated that phenol extraction, or 
even  protease  K  digestion,  failed  to  remove  all  added 
nuclease. In an attempt to circumvent this problem, material 
of fraction 4 was digested with micrococcal nuclease, taking 
advantage of the fact that the fraction was free of DNA and 
protein.  Digestion  conditions  were  designed  to  maintain 
EGTA in a concentration similar to that of lysate. The data 
indicated that 5 min of micrococcal nuclease digestion was 
sufficient to degrade 500 ng of fraction 4 to the point that it 
no  longer  inhibited  translation  of  adult  skeletal  muscle 
mRNA (Fig. 5, lane 6).  Patterns of (35S)methionine  incor- 
poration  were  equivalent  among  samples  of  5-30-min 
digests (Fig. 5, lanes 3-5) and adult total RNA in the absence 
of any addition (Fig. 5, lane 1 ). The presence of translational 
inhibitory activity associated with fraction 4, its sensitivity 
to ribonuclease, and the absence of inhibition after degrada- 
tion of RNA, confirms the presence of translational inhibi- 
tory activity associated with fraction 4, and that the inhibitor 
is indeed an RNA and is not dependent upon the presence 
of protein or ribonucleoprotein for its in vitro activity. 
Quantitation of the Inhibitory Effect of  Fraction 4 
Translational  inhibition has been operationally defined as 
that point at  which translation products can no longer be 
visualized by fluorography in comparison to control lanes 
without inhibitor. This procedure does not, however, lend it- 
self to a quantitative analysis of translation. Quantitation by 
measurement  of TCA-precipitable,  (35S)methionine  incor- 
Vanderburg and Nathanson Control of Muscle Protein Synthesis  1091 Figure  4.  Sensitivity  of embryonic poly A- RNA to enzyme digestions.  (a) Digestion  with DNase I. Lane 1, DNA standard  containing 
10 ttg of Hind III digested  lambda DNA; lane 2, DNAse I digest of the DNA standard;  lane 3, 10 lag of embryonic muscle poly A- RNA; 
lane 4, 10 lag of fraction 1 as defined in Fig.  1; lane 5, DNase I digest of 10 lag of fraction 1. (b) Protease K digestion  of DNase I-treated 
poly A- RNA. Lane 1, 2 lag of an RNA ladder; lane 2, 5 lag of undigested  RNA; lanes 3-6, digestion  for 1, 5,  10, and 20 min, respec- 
tively. The sizes of the components of the RNA ladder are indicated on the left margin. (c) Digestion with ribonuclease A. Lane 1, RNA 
ladder;  lane 2,  10 lag of a pool of fractions 2-5;  lanes  3-8, digestion  for 1, 5,  10, 20, 40, and 60 min, respectively.  The data indicated 
sensitivity  to RNase, confirming the RNA composition of fraction 4. 
Figure  5.  Sensitivity  of fraction 4 to micrococcal nuclease  diges- 
tion.  RNase sensitivity of fraction 4 was assessed by treating  DNA 
and protein-free  preparations  with  micrococcal nuclease;  the en- 
zyme should only degrade RNA under these  conditions.  Enzyme 
activity  was inhibited  by EGTA (see  Materials  and Methods)  and 
aliquots  containing  the original  equivalent  of 0.5 lag of fraction 4 
were added  to in vitro translations.  Lane 1, 0.25  lag adult  muscle 
total RNA in the absence of fraction 4; lane 2, 0.25 Ixg adult muscle 
total  RNA plus 0.5  lag undigested  fraction 4; lanes  3-7,  0.25  lag 
adult  muscle total RNA in the presence of fraction  4 digested  for 
30, 20,  10, 5, and 1 min,  respectively;  lane 8, (~4C)protein molecu- 
lar weight markers; lane  9, blank containing no added RNA. The 
data indicate that 5 min of nuclease  treatment  destroyed  inhibitory 
activity,  thus confirming the  RNA composition of the  inhibitor. 
poration has been performed using a translation assay con- 
mining 250 ng of adult or embryonic total RNA.  The data 
correlated well with previous findings; embryonic muscle to- 
tal RNA translated with only 40% of the efficiency of corre- 
sponding adult preparations when measured after 60 min of 
translation  in  vitro  (Fig.  6,  continuous  dashed  lines).  In- 
hibited  adult total  RNA directed the incorporation of only 
6,000  cpm;  with  reference  to  inhibition  shown  in  Figs.  2 
(fraction 4) and 5  (lane 2),  this low level of incorporation 
was apparently insufficient to resolve translation products at 
the  fluorographic  exposure  used  for  the  remainder  of the 
lanes.  The  translational  efficiency  of embryonic  poly  A + 
RNA was enhanced after oligo(dT) selection, thus stimulat- 
ing  incorporation  of label  into  protein  with  an  efficiency 
comparable to adult poly A ÷ RNA (Fig.  6, arrows on solid 
lines). These data are significant when viewed in conjunction 
with that presented in Table 1, clearly indicating that the in- 
hibitory  species  resides  within  the  poly A- component of 
embryonic muscle. 
TCA-precipitation assays have also been used to verify au- 
toradiographic results of inhibition by fraction 4. Inhibition 
has  been  calculated  as  the  decrease  in  area  under  related 
curves from the outset to 60 min. Addition of 500 ng of em- 
bryonic fraction 4 to translations primed with 250 ng of adult 
total  RNA  resulted  in  a  75%  decrease  in  incorporation  of 
label  at 60 min (Fig.  6 a).  Addition of the same amount of 
fraction 4  to 250 ng of embryonic total  RNA resulted  in a 
decrease of only 40%; addition of fraction 4 to adult or em- 
bryonic poly A ÷ RNA decreased  incorporation  by 45  and 
69%, respectively, at 60 min. The data resulting from addi- 
tions of fraction 4 to total RNA is particularly interesting in- 
sofar as translation of adult total RNA was reduced to levels 
comparable  to embryonic total  RNAs.  Further,  fraction  4 
was capable of inhibiting translation of adult poly A ÷ RNA 
to levels of adult total  RNA. 
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Figure 6. Quantitative analysis of 
translational inhibition. (a)  500 
ng of fraction 4 RNA was added 
to  in  vitro  translations primed 
with 250 ng of either adult total or 
adult poly A  + RNA.  Fraction 4 
inhibited translation of total RNA 
by  75%  and  poly  A  ÷ RNA  by 
45%  at  60  min.  (b)  500  ng of 
fraction 4 RNA was added to in 
vitro  translations  primed  with 
250 ng of either embryonic total 
or embryonic poly A  ÷ RNA. Ad- 
dition of fraction 4 inhibited trans- 
lation of total RNA by 40% and poly A  ÷ RNA by 69% at 60 min. (  ......  ), adult and embryonic total RNA; (  ........  ) adult and embryonic 
total RNA plus fraction 4; (  ) adult and embryonic poly A  + RNA; (  ....  ) adult and embryonic poly A  + RNA plus fraction 4. 
One  unsuspected  finding was  that  embryonic poly  A ÷ 
RNA directed a more rapid incorporation of label into pro- 
tein during the initial 15 min of translation than adult poly 
A ÷ RNA (compare solid lines of Fig. 6, a  and b). Thus, not 
only is the demonstrated inhibition  not due to transcriptional 
control, but it is also unaffected by the efficiency of the em- 
bryonic mRNA; embryonic poly A ÷ RNA appears to be a 
more  efficient message  than adult.  Differences  were  also 
noted  among absolute levels of incorporation, with  adult 
poly A ÷ RNA demonstrating continued translation through 
Figure  7.  Absence of nuclease activity  in the presence  of fraction 4.  (a) A 32p end-labeled, 7.5-kb RNA marker was added to in vitro 
translations primed with adult total RNA and embryonic fraction 4 (see text), recovered, and analyzed via methylmercury-agarose  gel elec- 
trophoresis  to detect nuclease activity. The marker was assumed to be intact since no changes in its mobility were detected in comparison 
to controls lacking input RNAs. Lanes 1 and 12, 5,000 cpm of 7.5-kb RNA marker (no translation); lane 2, 5,000 cpm of Hinf I pBR322 
ladder;  lane 3, 1,000 cpm gamma(32p)ATP did not resolve at the exposure used for the remainder of the lanes and its position is indicated 
by the arrow; lanes 4 and 5, 5,000 cpm of 7.5-kb RNA added to in vitro translations lacking input RNAs for 60 and 90 min, respectively; 
lanes 6-8, 5,000 cpm of 7.5-kb RNA plus 250 ng of adult muscle total RNA translated in vitro for 30, 60, and 90 min, respectively;  lanes 
9-11,  5,000 cpm of 7.5-kb RNA plus 250 ng of adult muscle total RNA and 500 ng of fraction 4 translated  in vitro for 30, 60, and 90 
rain, respectively. The 3 % agarose altered the migration of standards  in lane 2 and only those bands of verifiable length are indicated on 
the left margin. (b) Verification of size of the 7.5-kb marker RNA after translation in vitro. Hind III fragments of lambda DNA were used 
as standards. The data indicated that the marker RNA ran at a position of 7.5-kb before and after in vitro translation in inhibited and unin- 
hibited systems. Lanes 1 and 8, 5,000 cpm of 32p-labeled Hind III tambda DNA ladder (fragment  length indicated on left margin); lane 
2, 5,000 cpm of 7.5-kb RNA marker; lane 3, 5,000 cpm of 7.5-kb RNA added to an in vitro translation lacking input RNA for 90 min; 
lanes 4 and 5, 5,000 cpm of 7.5-kb RNA plus 250 ng of adult muscle total RNA translated  in vitro for 60 and 90 min, respectively;  lanes 
6 and 7, 5,000 cpm of 7.5-kb RNA plus 250 ng of adult muscle total RNA and 500 ng of fraction 4 RNA translated  in vitro for 60 and 
90 min, respectively. 
Vanderburg and Nathanson  Control of Muscle Protein Synthesis  1093 Figure 8.  Absence  of protein  from embryonic  muscle  poly A- 
RNA. RNase A digested preparations of embryonic poly A- RNA 
were analyzed by SDS-PAGE followed by silver staining. A plug of 
15% acrylamide was used to trap digestion products. Lane 1, 500 
ng protein molecular weight standard digested with RNase A for 
40 min. Molecular weights are indicated on the left border. Lanes 
2-3,  10 ~tg embryonic poly A- RNA digested with RNAse A for 
20 and 40 min,  respectively;  lane 4, blank; lane 5, 20 ng RNase 
A; lane 6,  10 ~tg undigested bovine total RNA; lane  7, 5 ~g un- 
digested RNA molecular weight standard; lane 8, 10 ~tg undigested 
embryonic poly A- RNA; lane 9,  10 ~tg undigested rabbit tRNA; 
lane 10, 5 I~g Hind III lambda DNA ladder. 
120  min, whereas embryonic preparations plateaued at 30 
min. The factor(s) responsible for the latter differences re- 
main unclear at the present time. 
Inhibition Is Not Due to Nuclease Activity 
or Ribonucleoprotein 
Inhibition associated with fraction 4 appears to be due to the 
action of an  RNA,  although  it  is  conceivable that a  ribo- 
nuclease  could  have  been  co-isolated,  or  induced  within 
reticulocyte lysate by  fraction 4.  This  activity,  if present, 
would degrade input RNA in a time-dependent fashion, lead- 
ing to reduced protein synthesis.  Experiments to assay for 
ribonuclease  activity were performed by adding  a  5' end- 
labeled, 7.5-kb RNA to in vitro translations primed with 250 
ng translatable RNA and 500 ng of fraction 4.  Degradation 
of the labeled marker RNA was measured by methylmercury 
gel electrophoresis after translation for up to 90 min and au- 
toradiography  of the  dried  gel.  Control  translations  were 
performed in  the  absence of fraction 4.  The data demon- 
strated  no  degradation  of end-labeled  RNA  in  either  the 
uninhibited or inhibited samples. The labeled marker RNA 
(Fig. 7 a,  lanes 1 and 12) did not show altered mobility or 
degradation after translation  in  the  absence of input RNA 
(lanes 4 and 5), or in the presence of adult total RNA (lanes 
6-8),  or adult total RNA and embryonic fraction 4  (lanes 
9-11 ). Lanes 6-8 and 9-11 represent translation for up to 90 
min. Degradation products were also absent at the position 
of free (32p)ATP (Fig. 7 a, arrow).  Lastly, the marker RNA 
was recovered from translations in the presence of adult total 
RNA or adult total plus  fraction 4  and  subjected  to elec- 
trophoresis  in  the  presence of a  DNA ladder.  These data 
confirmed that the marker remained undegraded  at 7.5  kb 
(Fig.  7 b). 
Each RNA preparation had been treated with protease K 
during its initial preparation. OD26o/280 ratios of 1.8-1.9  indi- 
cated  the  absence  of protein.  Absence  of changes  in  the 
ethidium bromide staining pattern after a second protease K 
treatment (cf. Fig. 4) lends assurance that ribonucleoprotein 
contamination of fraction 4 did not occur. As a further check 
on the  presence of ribonucleoprotein,  RNA  samples were 
degraded  by  protease-free RNase A  and  analyzed  for the 
presence of residual  protein by  silver staining  after SDS- 
PAGE (Fig.  8).  4-10%  gradient gels were cast above 15% 
acrylamide to retain digestion products. After degradation of 
all RNA, no stainable material was detected, suggesting that 
ribonucleoprotein  was  removed during  preparative proce- 
dures. 
The lnhibitor Acts at the Level of Initiation 
Experiments designed to clarify the mechanism of action of 
fraction 4  were performed by attempting to rescue transla- 
tion  through  addition  of either  increased  proportions  of 
reticulocyte  lysate  or  increased  amounts  of  translatable 
RNA.  Lysate contributes eukaryotic initiation  and elonga- 
tion  factors,  and  ribosomes.  Incorporation of (35S)methio- 
nine into protein was followed by SDS-PAGE and fluorogra- 
phy  and  quantitated  by  TCA  precipitation.  Addition  of 
fraction 4 was performed either simultaneously with compo- 
nents of the translation reaction, or to lysate 15 min before 
adding  message  (Fig.  9).  The  results  indicated  that  after 
simultaneous addition of all components, inhibition could be 
rescued by a fourfold increase in translatable message over 
that used in our standard assay or an 8 % increase in lysate. 
However, when fraction 4 was mixed with lysate 15 min be- 
fore adding RNA and beginning the reaction, it required a 
sixfold increase in translatable message to overcome inhibi- 
tion.  Addition of fraction 4  to lysate 15 min before adding 
a constant amount of translatable RNA required a >20% in- 
crease in lysate to overcome inhibition.  The results indicate 
an interaction with both mRNA and lysate, and a particularly 
strong interaction with components of lysate. On a mechanis- 
tic level, the data do not suggest a catalytic activity, but direct 
interference with protein synthesis. Absence of incomplete 
peptides in the fluorograms suggested further that the activ- 
ity of fraction 4  was directed towards initiation. 
To study initiation in vitro, we have used a translation sys- 
tem lacking factors for elongation (with the exception of eEF- 
tu;  necessary for translocation from the A  site to the P  site 
of the ribosome), and termination (Cenatiempo et al., 1983). 
In the presence of purified rabbit globin mRNA, and the first 
two amino acids of the beta globin polypeptide, the system 
should  generate  a  dipeptide  and  indicate  initiation.  The 
dipeptide (f-Met-[3H]val) was isolated chromatographically 
and quantitated by liquid scintillation counting.  The results 
demonstrated that in the presence of fraction 4, initiation was 
blocked in a dose-dependent manner (Fig.  10). 
The Journal of Cell Biology, Volume 107, 1988  1094 Figure 9. Rescue of translational inhibition. Rescue was attempted by addition of additional translatable (adult) RNA or lysate to standard 
translation assays containing 250 ng adult RNA and 500 ng fraction 4.  Controls consisted of translation  mixes in the absence of input 
RNA and translation of adult RNA alone. Adult RNA loads and the percent increase in lysate (vol) are indicated beneath each lane. Two 
types of experiments were performed for each series, including simultaneous addition of all components and addition of fraction 4 to lysate 
15 min before adding adult RNA.  See text for details. 
Discussion 
Differentiation of skeletal muscle, both in vivo and in vitro, 
is  primarily  regulated  by  transcriptional  control  mecha- 
nisms. However, the role of posttranscriptional regulation is 
gaining increased recognition in skeletal muscle and other 
eukaryotic  systems.  Posttranscriptional  events,  including 
transport of mRNA from the  nucleus  to cytoplasm in  the 
form of a ribonucleoprotein particle (Schwartz and Darnell, 
1976),  storage of mRNA in repressed RNP form (Darnell 
et  al.,  1973),  processing  of heterogeneous  nuclear  RNA 
(hnRNA; Lewin, 1975),  degradation of mRNA (Kafatos and 
Gelinas, 1974), and formation of RNA: RNA hybrids by an- 
tisense RNA (Green et al., 1986) have all been shown to con- 
trol the "availability" of message for translation  in eukary- 
otes. Further, binding of initiation factors to RNA (Grifo et 
al.,  1983),  unwinding of RNA secondary structure (Ray et 
al.,  1985), mRNA cap binding protein complex effects (Ed- 
cry et al., 1984), selection of translational start sites (Kozak, 
1984), and regulation of initiation, elongation, and termina- 
tion  factors  associated  with  ribosomes  (Moldave,  1985; 
Weissbach and Ochoa, 1976) have all been shown to regulate 
translation of mRNAs which are "available" 
The role of RNA molecules other than mRNA or rRNA 
in posttranscriptional control has also been studied.  These 
"control" RNAs are usually of small size, may or may not be 
associated with protein, and vary in their function and site 
of action upon posttranscriptional processes. One of these, 
small nuclear RNAs (snRNA;  see Busch and Reddy,  1985 
for review), are known to be involved in the processing and 
transport of hnRNA and  in the binding of regulatory pro- 
teins.  Low  molecular  weight  cytoplasmic  RNAs,  which 
affect translation  of mRNA,  have been identified  as  well. 
These RNAs differ from snRNA in that they are active in 
vitro  and  influence  translation  of mRNAs  that  are  fully 
processed and available for translation  (Sarkar,  1984). 
We have isolated an embryo-related poly A- RNA frac- 
tion from embryonic rat skeletal muscle. This 160-2,000-nt 
fraction  has  been  shown  to  inhibit  in  vitro translation  of 
skeletal muscle mRNA in an apparently nonspecific fashion. 
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bigure 10. Inhibition of initiation by fraction 4 RNA. Synthesis of 
the first dipeptide of beta globin (f-met-val) in vitro is dependent 
upon initiation in a reconstructed translation system lacking elonga- 
tion  factors.  The  dipeptide  was  quantitated  by counting  f-met- 
(3H)valine after a  1 h translation  at 37°C. Each point  represents 
the average of three determinations.  Blanks consisted of reactions 
containing fraction 4, but lacking beta-globin mRNA;  incorpora- 
tion in blanks has been subtracted from each point shown above. 
Dipeptide formation by beta-globin mRNA, in the absence of frac- 
tion 4, is indicated as zero inhibitor. A dose-dependent decrease in 
initiation was associated with addition of fraction 4 RNA to the 
system. 
Vanderburg and Nathanson Control of Muscle Protein Synthesis  1095 The ribonucleic acid composition of this inhibitor has been 
confirmed by differential enzymatic digestion. The inhibitor 
does not inhibit translation by induction of ribonuclease ac- 
tivity or through the presence of ribonucleoprotein that may 
have been co-isolated. The inhibitory mechanism is not fully 
understood at this time, but apparently involves a blockage 
of the initiation step of protein synthesis. This may ultimately 
be a consequence of the interaction of inhibitor with message 
or the translational apparatus, or perhaps through competi- 
tion for a ribosomal binding site. We propose that this inhibi- 
tor functions in translational control of muscle-specific pro- 
tein  synthesis,  acting  in  conjunction  with  transcriptional 
regulation of skeletal muscle differentiation. 
Low molecular weight inhibitory RNAs,  and the RNPs 
that they associate with, have been isolated from a variety of 
sources. Eller et al.  (1984) has isolated a >4-S RNA from 
cytoplasmic RNP of human term placenta which is an active 
inhibitor of translation in vitro. This inhibitor acts either in 
rabbit reticulocyte lysates or wheat germ extracts to inhibit, 
nonspecifically, the translation of added mRNA. Activity of 
the placental inhibitor is not dependent upon the presence of 
a cap structure, and appears to function by blocking initiation 
through an interaction with a component of the wheat germ 
extract. Bag et al. (1980) reported a very similar 4.4-S RNA 
from embryonic chicken muscle, which is found as a part of 
a 10-15-S RNP.  The RNP molecule and a 4.4-S RNA com- 
ponent were both active as translational inhibitors, but the 
protein components were inactive in the absence of RNA. 
However, it should be noted that one protein, a polypeptide 
with  a  molecular weight of 36,000  identified in the  RNP 
preparation, was absent from cellular mRNP and its role in 
posttranscriptional regulation is presently unclear. Another 
inhibitory RNA (iRNA) has been reported by Sarkar et al. 
(1981). Isolated from a  10-S iRNP of chick embryonic mus- 
cle, the 4-S iRNA was a potent inhibitor of translation in 
vitro. Winkler et al.  (1983) has shown that iRNA  inhibits 
translation at the initiation step by inhibiting mRNA binding 
to 43-S initiation complexes. He suggested that since iRNA 
blocks mRNA binding, it is possible that the relative affinity 
of message or inhibitor for the 43-S initiation complex acts 
to regulate translation based upon iRNA concentrations in 
the  cell.  Although  we have not proven that the  initiation 
block seen using our rat skeletal muscle inhibitory RNA is 
due to the mechanism proposed by Winkler et al., this mech- 
anism would explain the ability of additional message or ly- 
sate to rescue translation in our experiments. If we extend 
this proposed mechanism to include an interaction of inhibi- 
tory RNA with the ribosome, causing increased numbers of 
43-S initiation complexes, it may also explain the apparent 
increases in inhibition associated with adding inhibitor to the 
lysate 15 min before translation. Furthermore, the 40-fold in- 
crease in inhibitor purity that we report in the present experi- 
ments, would end the need for holding inhibitor and lysate 
together for extended periods to cause inhibition. 
Although the mechanism proposed above may suffice for 
all inhibitory RNAs that act nonspecifically, it does not ex- 
plain the mode of action of the myosin-specific tcRNA de- 
scribed by Heywood et al. (1975). tcRNA has most recently 
been described as a naturally occurring antisense RNA of 
eukaryotes (Heywood, 1986). Heywood has shown that the 
3' end of tcRNA contains  significant homology to 5' non- 
translated sequence of fast myosin heavy chain mRNA from 
chicken.  Cross-linking  studies  show close association be- 
tween these RNAs, and Heywood proposes translational in- 
hibition of myosin heavy chain synthesis due to blockage of 
initiation by RNA:  RNA hybridization, tcRNA is isolated 
from embryonic muscle of chicken,  as is iRNA.  It is  not 
clear whether a true dichotomy of inhibitor types is present 
in this muscle or if some aspects of an identical process are 
misunderstood. 
It is particularly interesting to note that many of the small 
cytoplasmic inhibitory RNAs have been isolated from em- 
bryonic sources, such as chicken muscle (Sarkar et al., 1981; 
Heywood et al., 1975), Artemia embryos (Piot et al., 1984), 
rabbit reticulocytes (Dionne et al., 1982), or from glandular 
tissues such as rat liver (Kuhn, 1982), placenta (Eller et al., 
1984),  Chinese hamster ovary (CHO; Jelinek,  1978),  and 
lactating guinea pig mammary gland (Bathurst et al., 1980). 
It is feasible that inhibitory RNAs are transcriptionally ex- 
pressed based upon developmental cues or during a state of 
secretory  activity  in  a  tissue.  We  have  investigated  the 
embryo-related nature of rat skeletal muscle inhibitory RNA 
by comparison of inhibitory activity of fractions from adult 
and embryonic sources. We found that inhibitor is present in 
the embryo, but not in the adult. This may be due to tran- 
scriptional control of inhibitor production or posttranscrip- 
tional control of inhibitor activity. Endo and Nadal-Ginard 
(1987) have recently uncovered evidence that protein synthe- 
sis in fusion-blocked rat myoblasts is subject to translational 
control.  These  authors  found  that  translation  of muscle- 
specific proteins was  inhibited in fusion-blocked myoblasts 
and  proposed  that  Ca  ++  dependent  mechanisms,  such  as 
ribosomal protein phosphorylation, are responsible for trans- 
lational arrest, although the factors involved in the transla- 
tional control they described have not yet been identified. 
What are the advantages of inhibitory translational control 
to  a  developing or  secretory cell type already  under the 
influence of well-defined transcriptional controls? Transcrip- 
tional control in eukaryotes must be far more complex than 
that of prokaryotes owing to the diversity of proteins pro- 
duced. If a class or classes of transcript production are sud- 
denly activated within a eukaryotic cell, it may be advanta- 
geous to create a "lag time" in which new transcripts can be 
fully processed and transported or stored in the cytoplasm 
before translation. Degradation of obsolete messages takes 
time to occur after cessation of their transcription. Transla- 
tionally inhibitory RNAs  could also  serve to balance the 
amounts of each protein produced in a cell by giving the tran- 
scriptional apparatus time to produce the correct proportions 
of message before translation.  These proportions are un- 
doubtedly critical to the structural requirements of a differen- 
tiating cell. 
We have shown that postfusion myoblasts contain transla- 
tionally active muscle specific mRNAs at, or near, adult lev- 
els, but the production of proteins from these messages is 
delayed for a number of days, apparently due to translational 
control. We are currently investigating the quantities of in- 
hibitory RNA in embryonic stages from the time of myoblast 
fusion to adulthood.  We suggest that translational  control 
RNAs,  which by themselves are subject to transcriptional 
and posttranscriptional control, act in conjunction with clas- 
sical transcriptional and posttranscriptional mechanisms to 
fine tune the timing of muscle differentiation. 
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